Contact this trialFirst, we need to learn more about you.
Anti-cancer Drug
SNDX-5613 for Acute Myeloid Leukemia
Recruiting1 awardPhase 1
Chicago, Illinois
"This trial is testing the safety and effectiveness of a new drug called SNDX-5613 in combination with standard chemotherapy for treating patients with a specific type of leukemia. SNDX-5613 works by
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.